Skip to main content
. 2023 May 31;13:1206111. doi: 10.3389/fcimb.2023.1206111
AC astrocyte cell
ADCC antibody-dependent cellular cytotoxicity
ADCP antibody-dependent cellular phagocytosis
BBD beclin 1 binding domain
BMP4 bone morphogenetic protein 4
CSC cancer stem cell
DGC differentiated glioblastoma cell
DSB double-strand DNA break
E early
ED50 median effective dose
EGFR epidermal growth factor receptor
GBM glioblastoma
GEM genetically engineered mouse
GSC glioblastoma stem-like cell
h human
HGG high-grade glioma
HDAC histone deacetylase
m mouse
ICI Immune checkpoint inhibitor
IDH isocitrate dehydrogenase
IE immediate early
L late
MES mesenchymal
MGMT O6-methylguanine-DNA methyltransferase
MOI multiplicity of infection
MRI magnetic resonance imaging
oHSV oncolytic herpes simplex virus
OPC oligodendrocyte progenitor cell
OV oncolytic virus
PDX patient-derived xenograft
PARP poly(ADP-ribose) polymerase
pfu plaque forming unit
RR ribonucleotide reductase
ScGC serum-cultured GBM cells
TGFβ transforming growth factor-β
TGFβ receptor TGFβ
TIL tumor-infiltrating lymphocytes
TK thymidine kinase
TME tumor microenvironment
TMZ temozolomide
Treg T regulatory cell.